Study Details

General Information

Forest Hypertension NAC-MD-03

A Multi-Center, Double-Blind, Placebo-Controlled, 8-Week Study to Evaluate the Effects of Treatment with Fixed-Dose Combinations of Nebivolol and Valsartan in Patients with Stage 2 Essential Hypertension.

ProtocolNAC-MD-03
IdentifierNAC-MD-03 Site Number 25
UID2f682e21-b17d-42ec-b07d-d58da07c6045
StatusCancelled
Phase3B
CategoryHypertension / Adult
Launch Year0
NCT Number-
Created2014-02-03 18:49
Last Updated2014-02-03 18:49

Description

No description provided.

Comment

No comment.

Target Dates

NameDateRequired
Enrollment ClosedNo
Enrollment OpenNo
First Patient First VisitNo
Site Initiation Mtg.No
PI Meeting StartNo
PI Meeting EndNo
PI Meeting ArrivalNo
PI Meeting DepartureNo
Closeout DateNo
Final PatientVisitNo
PreStudy Selection VisitNo
Target Date 12No
Target Date 13No
Target Date 14No

Leadership

RoleStaffLoginRequired
PrincipalMartinez, GilbertGJMartinezNo
Recruiter-No
CoordinatorPereira, CynthiaCPereiraNo
RegulatoryValenzuela, LouisitoLValenzuelaNo

Custom Fields

No custom fields.

Sponsor & Organization

SponsorForest Research Institute
DivisionForest Research Institute
TeamForest Research Institute
Managing SiteCatalina Research Institute, LLC
Organization

Contacts

IRB Ref
CRO
CRO Ref
Correspondence0

Opportunity

Probability0
Comment
Status ColorYellow
Currency-
Mayra Sibley

2 Hours

Hi there, I'm Jesse and you?
You

3 minutes

My name is Anne Clarc.
Mayra Sibley

40 seconds

Nice to meet you Anne.
How can i help you?